These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 21931792)
1. A selectable and excisable marker system for the rapid creation of recombinant poxviruses. Rintoul JL; Wang J; Gammon DB; van Buuren NJ; Garson K; Jardine K; Barry M; Evans DH; Bell JC PLoS One; 2011; 6(9):e24643. PubMed ID: 21931792 [TBL] [Abstract][Full Text] [Related]
11. The uses of poxviruses as vectors. Vanderplasschen A; Pastoret PP Curr Gene Ther; 2003 Dec; 3(6):583-95. PubMed ID: 14683453 [TBL] [Abstract][Full Text] [Related]
12. Transient selection during vaccinia virus recombination with insertion vectors without selectable markers. Kurilla MG Biotechniques; 1997 May; 22(5):906-10. PubMed ID: 9149873 [TBL] [Abstract][Full Text] [Related]
13. Engineering recombinant poxviruses using a compact GFP-blasticidin resistance fusion gene for selection. Wong YC; Lin LC; Melo-Silva CR; Smith SA; Tscharke DC J Virol Methods; 2011 Jan; 171(1):295-8. PubMed ID: 21073901 [TBL] [Abstract][Full Text] [Related]
14. A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9. Yuan M; Gao X; Chard LS; Ali Z; Ahmed J; Li Y; Liu P; Lemoine NR; Wang Y Mol Ther Methods Clin Dev; 2015; 2():15035. PubMed ID: 26417609 [TBL] [Abstract][Full Text] [Related]
15. Heat shock induced excision of selectable marker genes in transgenic banana by the Cre-lox site-specific recombination system. Chong-Pérez B; Kosky RG; Reyes M; Rojas L; Ocaña B; Tejeda M; Pérez B; Angenon G J Biotechnol; 2012 Jun; 159(4):265-73. PubMed ID: 21839123 [TBL] [Abstract][Full Text] [Related]
16. Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA. Smith GL; Moss B Gene; 1983 Nov; 25(1):21-8. PubMed ID: 6229451 [TBL] [Abstract][Full Text] [Related]
17. Two novel poxviruses with unusual genome rearrangements: NY_014 and Murmansk. Smithson C; Meyer H; Gigante CM; Gao J; Zhao H; Batra D; Damon I; Upton C; Li Y Virus Genes; 2017 Dec; 53(6):883-897. PubMed ID: 28762208 [TBL] [Abstract][Full Text] [Related]
18. Poxvirus vaccines for cancer and HIV therapy. Essajee S; Kaufman HL Expert Opin Biol Ther; 2004 Apr; 4(4):575-88. PubMed ID: 15102606 [TBL] [Abstract][Full Text] [Related]
19. Construction of Marker-Free Genetically Modified Maize Using a Heat-Inducible Auto-Excision Vector. Du D; Jin R; Guo J; Zhang F Genes (Basel); 2019 May; 10(5):. PubMed ID: 31108922 [TBL] [Abstract][Full Text] [Related]
20. Recombinant poxviruses as mucosal vaccine vectors. Gherardi MM; Esteban M J Gen Virol; 2005 Nov; 86(Pt 11):2925-2936. PubMed ID: 16227213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]